The European Commission has published the first-ever Continuous Monitoring Report for the European Reference Networks (ERNs), covering the 2023–2024 reporting period. This milestone report compiles data from more than 1,600 clinical units across 375 hospitals in 27 EU Member States and Norway, offering the most comprehensive overview yet of ERN activity and impact since their launch in 2017.
The report presents detailed indicators across the ERN system’s seven core areas — clinical activity, cross-border collaboration (CPMS), registries, training, guidelines, dissemination and coordination — providing a clear picture of how ERNs support patients with rare diseases across Europe. It highlights a [...]
Continue reading →
REGISTER NOW for the upcoming 2026 I-DSD Symposium scheduled 1-3 July, Lübeck, Germany.
Endo-ERN is pleased to endorse the 2026 I-DSD Symposium, bringing together global experts, clinicians, and patient representatives to advance care and research in DSD.
The three-day programme covers biological sex development, fertility preservation, quality of care benchmarking, hormones and athletic performance, innovations in hormone therapies, and surgical outcomes.
A half-day I-DSD Training Workshop on 1 July offers practical sessions on diagnostics, communication, hormone replacement, registries, and sex therapy.
Full agenda and [...]
Continue reading →
Register now for the next Endo-ERN webinar An update on genetics and clinical management of tall stature planned for Tuesday, 17 February from 17:00-18:00 CET.
During this webinar you will find out more about the diagnosis and treatment of tall stature a condition where children born with normal range for weight and length exhibit accelerated growth during childhood. Familial tall stature is the most common cause, followed by constitutional tall stature but tall stature is also seen in many uncommon conditions.
Speaker: Lars Sävendahl, Professor and Chief of Pediatric Endocrinology at Karolinska Institutet and Scientific Director of [...]
Continue reading →
The 13th European Conference on Rare Diseases & Orphan Products (ECRD 2026) will take place 3–4 June 2026, in person in Prague and online. Organised by EURORDIS-Rare Diseases Europe, co-organised by Orphanet, and supported by AFM-Téléthon, ECRD is Europe’s largest, patient-led, policy-shaping event for the rare disease community. The 2026 edition, titled Rare Diseases in a Changing & Competitive Europe: Shaping policies to address the unmet needs of people living with rare diseases, will mark the launch of a multi-stakeholder process to develop a European Action Plan for Rare Diseases.
Poster abstract submissions for [...]
Continue reading →
The European Rare Disease Research Alliance (ERDERA) has pre-announced its upcoming 2026 Joint Transnational Call (JTC):
Launching on 10 December 2025, this initiative will fund multinational research collaborations aimed at improving diagnostic clarity for patients whose rare diseases remain unsolved. An information webinar for potential applicants will take place on 16 December 2025, 15:00–17:00 CET.
The call will welcome proposals under the theme:
Resolving unsolved cases in rare genetic and non-genetic diseases through variant validation and new technological approaches
Access the pre‑announcement
An informational [...]
Continue reading →
Register now for the European Society of Endocrinology (ESE) Hypoparathyroidism Patient Forum 2025 taking place on Saturday, 15 November from 10:00-13:00 CET.
Programme highlights:
🔹 Social Impact of Hypoparathyroidism – chaired by Prof. Andrea Giustina & Prof. Alberto Pereira
• François Houÿez, EURORDIS – amplifying the rare disease patient voice in Health Technology Assessment
• Prof. Heide Siggelkow – new insights on quality of life and social impact
• Natalie Grosset – the patient journey
🔹 Revised ESE Guidelines [...]
Continue reading →
The European Commission has opened a consultation on the draft Multiannual Financial Framework (MFF) — the EU’s long-term budget plan.
In the current proposal, rare diseases are not explicitly mentioned, and the EU4Health programme no longer appears as a standalone initiative.
European Reference Networks (ERNs) — established by the European Commission in 2017 — have become a cornerstone of the EU’s strategy to improve diagnosis, treatment, and care for people living with rare and complex conditions by connecting healthcare providers and specialists across Member States. The omission of ERNs and rare [...]
Continue reading →
Register now for a webinar from MTG6 planned for Tuesday, 24 March 16:00-18:00 CET.
Webinar Chair: Prof. Nienke R. Biermasz Endo-ERN MTG6 Adult Chair
Agenda / Presentations:
Key Challenges in Neurosurgical Management of Cushing’s Disease
Prof. Leszek Sagan, Department of Neurosurgery and Pediatric Neurosurgery, Pomeranian Medical University in Szczecin, Poland
Beyond the Cure: Quality of Life in Patients with Cushing’s Disease in Remission
Dr. Karol Piotr Sagan, Department of Endocrinology, Metabolic and Internal Diseases, Pomeranian Medical University in Szczecin, Poland
Quality of Life After Pituitary Surgery in Cushing’s Disease – A Patient’s View
Ms. Marta Barańska, MBA in Health Care, [...]
Continue reading →
